TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc.

No trades
See on Supercharts

RNAZ fundamentals

The current financial position of TransCode Therapeutics, Inc.

Total assets of RNAZ for Q1 25 is 13.19 M USD, 80.88% more than the previous Q4 24. And total liabilities decreased by 68.84% in Q1 25 to 2.9 M USD.

Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total assets
Total liabilities
Currency: USD
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total assetsYoY growth
Total equityYoY growth